vs
Astrana Health, Inc.（ASTH）与玛斯特锁（MBC）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是玛斯特锁的1.5倍（$950.5M vs $618.0M），Astrana Health, Inc.同比增速更快（42.9% vs -6.4%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-146.2M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -4.4%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
玛斯特锁是美国知名安防产品供应商，1921年由锁匠发明家哈里·索雷夫创立，总部位于威斯康星州奥克里克，主营挂锁、密码锁、保险箱及相关安防产品，现为富俊创新集团旗下子公司，在全球安防锁具领域拥有较高的市场认可度。
ASTH vs MBC — 直观对比
营收规模更大
ASTH
是对方的1.5倍
$618.0M
营收增速更快
ASTH
高出49.3%
-6.4%
自由现金流更多
ASTH
多$140.3M
$-146.2M
两年增速更快
ASTH
近两年复合增速
-4.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $618.0M |
| 净利润 | $6.6M | — |
| 毛利率 | — | 25.3% |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | — |
| 营收同比 | 42.9% | -6.4% |
| 净利润同比 | 184.4% | — |
| 每股收益（稀释后） | $0.12 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHMBC
| Q1 26 | — | $618.0M | ||
| Q4 25 | $950.5M | $644.6M | ||
| Q3 25 | $956.0M | $698.9M | ||
| Q2 25 | $654.8M | $730.9M | ||
| Q1 25 | $620.4M | $660.3M | ||
| Q4 24 | $665.2M | $667.7M | ||
| Q3 24 | $478.7M | $718.1M | ||
| Q2 24 | $486.3M | $676.5M |
净利润ASTHMBC
| Q1 26 | — | — | ||
| Q4 25 | $6.6M | $-42.0M | ||
| Q3 25 | $373.0K | $18.1M | ||
| Q2 25 | $9.4M | $37.3M | ||
| Q1 25 | $6.7M | $13.3M | ||
| Q4 24 | $-7.8M | $14.0M | ||
| Q3 24 | $16.1M | $29.1M | ||
| Q2 24 | $19.2M | $45.3M |
毛利率ASTHMBC
| Q1 26 | — | 25.3% | ||
| Q4 25 | — | 26.0% | ||
| Q3 25 | — | 31.2% | ||
| Q2 25 | — | 32.8% | ||
| Q1 25 | — | 30.6% | ||
| Q4 24 | — | 30.4% | ||
| Q3 24 | — | 33.1% | ||
| Q2 24 | — | 34.1% |
营业利润率ASTHMBC
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | -4.2% | ||
| Q3 25 | 2.0% | 6.0% | ||
| Q2 25 | 3.1% | 9.2% | ||
| Q1 25 | 3.3% | 5.6% | ||
| Q4 24 | 0.1% | 5.6% | ||
| Q3 24 | 5.9% | 8.0% | ||
| Q2 24 | 6.2% | 11.5% |
净利率ASTHMBC
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | -6.5% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 1.4% | 5.1% | ||
| Q1 25 | 1.1% | 2.0% | ||
| Q4 24 | -1.2% | 2.1% | ||
| Q3 24 | 3.4% | 4.1% | ||
| Q2 24 | 3.9% | 6.7% |
每股收益（稀释后）ASTHMBC
| Q1 26 | — | $-0.12 | ||
| Q4 25 | $0.12 | $-0.32 | ||
| Q3 25 | $0.01 | $0.14 | ||
| Q2 25 | $0.19 | $0.29 | ||
| Q1 25 | $0.14 | $0.10 | ||
| Q4 24 | $-0.14 | $0.10 | ||
| Q3 24 | $0.33 | $0.22 | ||
| Q2 24 | $0.40 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $138.4M |
| 总债务越低越好 | — | $1.1B |
| 股东权益账面价值 | $779.3M | $1.3B |
| 总资产 | $2.2B | $3.1B |
| 负债/权益比越低杠杆越低 | — | 0.82× |
8季度趋势，按日历期对齐
现金及短期投资ASTHMBC
| Q1 26 | — | $138.4M | ||
| Q4 25 | $429.5M | $183.3M | ||
| Q3 25 | $463.4M | $114.8M | ||
| Q2 25 | $342.1M | $120.1M | ||
| Q1 25 | $260.9M | $113.5M | ||
| Q4 24 | $290.8M | $120.6M | ||
| Q3 24 | $350.3M | $108.4M | ||
| Q2 24 | $327.7M | $189.4M |
总债务ASTHMBC
| Q1 26 | — | $1.1B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | — |
股东权益ASTHMBC
| Q1 26 | — | $1.3B | ||
| Q4 25 | $779.3M | $1.3B | ||
| Q3 25 | $775.5M | $1.4B | ||
| Q2 25 | $765.5M | $1.4B | ||
| Q1 25 | $745.4M | $1.3B | ||
| Q4 24 | $712.7M | $1.3B | ||
| Q3 24 | $704.6M | $1.3B | ||
| Q2 24 | $678.9M | $1.3B |
总资产ASTHMBC
| Q1 26 | — | $3.1B | ||
| Q4 25 | $2.2B | $3.1B | ||
| Q3 25 | $2.2B | $3.0B | ||
| Q2 25 | $1.4B | $3.0B | ||
| Q1 25 | $1.3B | $3.0B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.3B | $3.0B | ||
| Q2 24 | $1.3B | $2.4B |
负债/权益比ASTHMBC
| Q1 26 | — | 0.82× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-133.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-146.2M |
| 自由现金流率自由现金流/营收 | -0.6% | -23.7% |
| 资本支出强度资本支出/营收 | 0.3% | 2.1% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $12.5M |
8季度趋势，按日历期对齐
经营现金流ASTHMBC
| Q1 26 | — | $-133.0M | ||
| Q4 25 | $-2.9M | $86.9M | ||
| Q3 25 | $10.0M | $55.4M | ||
| Q2 25 | $90.9M | $84.8M | ||
| Q1 25 | $16.6M | $-31.4M | ||
| Q4 24 | $-10.9M | $115.1M | ||
| Q3 24 | $34.0M | $80.8M | ||
| Q2 24 | $23.2M | $77.4M |
自由现金流ASTHMBC
| Q1 26 | — | $-146.2M | ||
| Q4 25 | $-6.0M | $52.5M | ||
| Q3 25 | $7.4M | $39.5M | ||
| Q2 25 | $89.5M | $66.7M | ||
| Q1 25 | $13.6M | $-41.2M | ||
| Q4 24 | $-13.5M | $68.8M | ||
| Q3 24 | $31.7M | $64.5M | ||
| Q2 24 | $20.4M | $66.1M |
自由现金流率ASTHMBC
| Q1 26 | — | -23.7% | ||
| Q4 25 | -0.6% | 8.1% | ||
| Q3 25 | 0.8% | 5.7% | ||
| Q2 25 | 13.7% | 9.1% | ||
| Q1 25 | 2.2% | -6.2% | ||
| Q4 24 | -2.0% | 10.3% | ||
| Q3 24 | 6.6% | 9.0% | ||
| Q2 24 | 4.2% | 9.8% |
资本支出强度ASTHMBC
| Q1 26 | — | 2.1% | ||
| Q4 25 | 0.3% | 5.3% | ||
| Q3 25 | 0.3% | 2.3% | ||
| Q2 25 | 0.2% | 2.5% | ||
| Q1 25 | 0.5% | 1.5% | ||
| Q4 24 | 0.4% | 6.9% | ||
| Q3 24 | 0.5% | 2.3% | ||
| Q2 24 | 0.6% | 1.7% |
现金转化率ASTHMBC
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 3.06× | ||
| Q2 25 | 9.65× | 2.27× | ||
| Q1 25 | 2.48× | -2.36× | ||
| Q4 24 | — | 8.22× | ||
| Q3 24 | 2.11× | 2.78× | ||
| Q2 24 | 1.21× | 1.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MBC
暂无分部数据
